Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases.

IF 5.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Hao Wang, Yingjie Zhao, Fuli Zhou, Fan Chen, Tianyu Chen, Jinhong Wang, Hao Liu, Cheng Sun, Renpeng Zhou, Wei Hu, Chao Lu
{"title":"Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases.","authors":"Hao Wang, Yingjie Zhao, Fuli Zhou, Fan Chen, Tianyu Chen, Jinhong Wang, Hao Liu, Cheng Sun, Renpeng Zhou, Wei Hu, Chao Lu","doi":"10.1089/ars.2024.0793","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Significance:</i></b> Oxidative stress is a key factor in inducing cellular senescence and age-related diseases. When the redox balance within the body is disrupted, sustained oxidative stress can lead to cellular senescence. The accumulation of senescent cells, in turn, triggers a variety of age-related diseases. Peroxiredoxin 6 (Prdx6) is a critical target in the intracellular regulation of redox homeostasis. <b><i>Recent Advances:</i></b> Prdx6 is a widely expressed antioxidant enzyme and the sole member of the peroxiredoxin family endowed with multiple enzymatic functions, including peroxidase activity along with acidic calcium-independent phospholipase A2 (aiPLA2) and lysophosphatidylcholine acyltransferase (LPCAT) activities. Its fundamental physiological functions involve protecting against oxidative stress and maintaining phospholipid homeostasis. Recent studies have shown that Prdx6 is widely involved in the regulation of cellular senescence and influences the development and progression of various age-related diseases. <b><i>Critical Issues:</i></b> Cellular senescence and age-related diseases, due to their complex mechanisms, lack effective treatments. Therefore, there is an urgent need to identify new therapeutic targets. This review discusses the biological characteristics of Prdx6 and its pathophysiological roles in cellular senescence and age-related diseases. Prdx6 may serve as a potential target for modulating cellular senescence and age-related diseases. <b><i>Future Directions:</i></b> The regulatory mechanisms of Prdx6 in age-related diseases warrant further investigation. Additionally, conducting drug screening to identify more molecules that can specifically target Prdx6 will provide new strategies for the treatment of age-related diseases. <i>Antioxid. Redox Signal.</i> 00, 000-000.</p>","PeriodicalId":8011,"journal":{"name":"Antioxidants & redox signaling","volume":" ","pages":""},"PeriodicalIF":5.9000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antioxidants & redox signaling","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/ars.2024.0793","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Significance: Oxidative stress is a key factor in inducing cellular senescence and age-related diseases. When the redox balance within the body is disrupted, sustained oxidative stress can lead to cellular senescence. The accumulation of senescent cells, in turn, triggers a variety of age-related diseases. Peroxiredoxin 6 (Prdx6) is a critical target in the intracellular regulation of redox homeostasis. Recent Advances: Prdx6 is a widely expressed antioxidant enzyme and the sole member of the peroxiredoxin family endowed with multiple enzymatic functions, including peroxidase activity along with acidic calcium-independent phospholipase A2 (aiPLA2) and lysophosphatidylcholine acyltransferase (LPCAT) activities. Its fundamental physiological functions involve protecting against oxidative stress and maintaining phospholipid homeostasis. Recent studies have shown that Prdx6 is widely involved in the regulation of cellular senescence and influences the development and progression of various age-related diseases. Critical Issues: Cellular senescence and age-related diseases, due to their complex mechanisms, lack effective treatments. Therefore, there is an urgent need to identify new therapeutic targets. This review discusses the biological characteristics of Prdx6 and its pathophysiological roles in cellular senescence and age-related diseases. Prdx6 may serve as a potential target for modulating cellular senescence and age-related diseases. Future Directions: The regulatory mechanisms of Prdx6 in age-related diseases warrant further investigation. Additionally, conducting drug screening to identify more molecules that can specifically target Prdx6 will provide new strategies for the treatment of age-related diseases. Antioxid. Redox Signal. 00, 000-000.

过氧化物还氧蛋白6:细胞衰老和年龄相关疾病的调控靶点
意义:氧化应激是诱导细胞衰老和衰老相关疾病的关键因素。当体内氧化还原平衡被破坏时,持续的氧化应激可导致细胞衰老。衰老细胞的积累反过来又引发了各种与年龄有关的疾病。过氧化氧还蛋白6 (Prdx6)是细胞内氧化还原稳态调控的关键靶点。Prdx6是一种广泛表达的抗氧化酶,是过氧化氧还蛋白家族的唯一成员,具有多种酶功能,包括过氧化物酶活性以及酸性钙非依赖性磷脂酶A2 (aiPLA2)和溶血磷脂酰转移酶(LPCAT)活性。它的基本生理功能包括防止氧化应激和维持磷脂稳态。最近的研究表明,Prdx6广泛参与细胞衰老的调控,并影响各种年龄相关疾病的发生和进展。关键问题:细胞衰老和与年龄相关的疾病,由于其复杂的机制,缺乏有效的治疗。因此,迫切需要寻找新的治疗靶点。本文就Prdx6的生物学特性及其在细胞衰老和年龄相关疾病中的病理生理作用作一综述。Prdx6可能作为调节细胞衰老和年龄相关疾病的潜在靶点。未来方向:Prdx6在年龄相关疾病中的调控机制有待进一步研究。此外,进行药物筛选以确定更多可以特异性靶向Prdx6的分子将为治疗年龄相关疾病提供新的策略。Antioxid。氧化还原信号:00000 - 00000。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Antioxidants & redox signaling
Antioxidants & redox signaling 生物-内分泌学与代谢
CiteScore
14.10
自引率
1.50%
发文量
170
审稿时长
3-6 weeks
期刊介绍: Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas. ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes. ARS coverage includes: -ROS/RNS as messengers -Gaseous signal transducers -Hypoxia and tissue oxygenation -microRNA -Prokaryotic systems -Lessons from plant biology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信